LadRx Corp — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-C
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
11-K
25-NSE
3
3/A
4
4/A
424B2
424B3
424B5
425
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DEFN14A
DEFS14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PREM14A
PRES14A
PRRN14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | — | 0001493152-19-017120 | Nov 14, 2019 | Sep 30, 2019 |
| 8-K | — | 0001493152-19-013480 | Aug 29, 2019 | — |
| 10-Q | — | 0001493152-19-011945 | Aug 9, 2019 | Jun 30, 2019 |
| DEFA14A | — | 0001493152-19-011498 | Aug 1, 2019 | — |
| 8-K | — | 0001493152-19-011497 | Aug 1, 2019 | Jul 30, 2019 |
| DEF 14A | — | 0001493152-19-009715 | Jun 26, 2019 | — |
| 8-K | — | 0001493152-19-009716 | Jun 26, 2019 | Jun 25, 2019 |
| 25-NSE | — | 0001354457-19-000332 | Jun 24, 2019 | — |
| SC 13G | SC 13G | 0001193125-19-167238 | Jun 6, 2019 | — |
| 8-K | — | 0001493152-19-008444 | May 31, 2019 | May 24, 2019 |
| 10-Q | — | 0001493152-19-007215 | May 15, 2019 | Mar 31, 2019 |
| 10-K | — | 0001493152-19-004165 | Mar 29, 2019 | Dec 31, 2018 |
| 8-K | — | 0001493152-19-000632 | Jan 15, 2019 | — |
| SC 13G/A | SABBY 13G-A CYTR 1.04.19 | 0001535610-19-000033 | Jan 4, 2019 | — |
| 8-K | — | 0001493152-18-016874 | Nov 29, 2018 | — |
| 10-Q | — | 0001493152-18-015120 | Nov 2, 2018 | Sep 30, 2018 |
| 8-K | VOTING RESULTS FROM 2018 ANNUAL MEETING OF STOCKHOLDERS | 0000799698-18-000018 | Aug 13, 2018 | Aug 9, 2018 |
| 8-K | WEBCAST AND EARNINGS RELEASE FOR SECOND QUARTER 2018 | 0000799698-18-000017 | Aug 10, 2018 | Aug 6, 2018 |
| 10-Q | — | 0001493152-18-010972 | Aug 6, 2018 | Jun 30, 2018 |
| DEFA14A | SUPPLEMENT TO DEFINITIVE 14A PROXY STATEMENT FIRST FILED JULY 5, 2018. | 0000799698-18-000016 | Jul 19, 2018 | — |
| DEF 14A | — | 0001493152-18-009705 | Jul 5, 2018 | — |
| 8-K | CURRENT REPORT ON FORM 8-K NOTING AMENDMENT OF BYLAWS | 0000799698-18-000015 | Jun 22, 2018 | Jun 18, 2018 |
| 8-K | CURRENT REPORT ON FORM 8-K CONCERNING FORMATION OF SUBSIDIARY | 0000799698-18-000013 | Jun 4, 2018 | Jun 1, 2018 |
| 3 | FORM 3 | 0001140361-18-024923 | May 21, 2018 | May 3, 2018 |
| 8-K | FORM 8-K FOR REGISTERED DIRECT OFFERING | 0000799698-18-000012 | May 16, 2018 | May 11, 2018 |
| SC 13G | SABBY 13G CYTR 5.15.18 | 0001535610-18-000086 | May 15, 2018 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001615774-18-003654 | May 11, 2018 | — |
| 10-Q | QUARTERLY REPORT ON SEC FORM 10-Q FOR QUARTER ENDED MARCH 31, 2018 | 0000799698-18-000010 | May 8, 2018 | Mar 31, 2018 |
| 8-K | CURRENT REPORT ON FORM 8-K FOR 1ST QUARTER EARNINGS PRESS RELEASE | 0000799698-18-000011 | May 8, 2018 | — |
| 8-K | CURRENT REPORT ON FORM 8-K ANNOUNCING THE APPOINTMENT OF ERIC L. CURTIS | 0000799698-18-000009 | May 7, 2018 | May 2, 2018 |
| 424B3 | FINAL PROSPECTUS FOR 97,929 SHARES. | 0000799698-18-000008 | Apr 2, 2018 | — |
| EFFECT | — | 9999999995-18-000734 | Apr 2, 2018 | — |
| UPLOAD | — | 0000000000-18-009308 | Mar 27, 2018 | — |
| CORRESP | — | 0000799698-18-000007 | Mar 27, 2018 | — |
| 8-K | DISCLOSURE OF EMPLOYMENT AGREEMENT WITH FELIX KRATZ, PH.D. | 0000799698-18-000006 | Mar 22, 2018 | Mar 16, 2018 |
| S-3 | REGISTRATION OF UP TO 97,929 OUTSTANDING SHARES OF CYTRX COMMON STOCK. | 0000799698-18-000005 | Mar 21, 2018 | — |
| 8-K | 2017 EARNINGS RELEASE ON FORM 8-K | 0000799698-18-000003 | Mar 19, 2018 | — |
| 10-K | FORM 10-K FOR CYTRX CORPORATION FOR PERIOD ENDING DECEMBER 17, 2017 | 0000799698-18-000002 | Mar 16, 2018 | Dec 31, 2017 |
| 8-K | DISCLOSURE OF 2018 EMPLOYMENT AGREEMENT WITH JOHN CALOZ. | 0000799698-18-000001 | Mar 1, 2018 | Feb 26, 2018 |
| SC 13G/A | SABBY 13G-A CYTR 1.09.18 | 0001535610-18-000040 | Jan 9, 2018 | — |
| 4 | FORM 4 | 0001140361-18-000228 | Jan 2, 2018 | Dec 15, 2017 |
| 3 | FORM 3 | 0001140361-18-000208 | Jan 2, 2018 | Dec 15, 2017 |
| 4 | FORM 4 | 0001140361-17-046691 | Dec 19, 2017 | Dec 15, 2017 |
| 4 | FORM 4 | 0001140361-17-046688 | Dec 19, 2017 | Dec 15, 2017 |
| 4 | FORM 4 | 0001140361-17-046689 | Dec 19, 2017 | Dec 15, 2017 |
| 4 | FORM 4 | 0001140361-17-046690 | Dec 19, 2017 | Dec 15, 2017 |
| 4 | FORM 4 | 0001140361-17-046692 | Dec 19, 2017 | Dec 15, 2017 |
| 8-K | DISCLOSURE OF EARNINGS RELEASE FOR 3RD QUARTER 2017 | 0000799698-17-000039 | Nov 9, 2017 | Nov 8, 2017 |
| 8-K | DISCLOSURE OF STRATEGIC REALIGNMENT OF DRUG DEVELOPMENT ACTIVITIES | 0000799698-17-000037 | Nov 8, 2017 | Oct 31, 2017 |
| 10-Q | QUARTERLY REPORT ON FORM 10-Q FOR QUARTER ENDED 2017-09-30. | 0000799698-17-000038 | Nov 8, 2017 | Sep 30, 2017 |